Research Idea
Research content for general circulation. Not individualized advice.Ā Methodology & Disclosures
LFST gained 7.7% over 21 sessions and closed at a period high on September 10. Revenue grew 16%, free cash flow reached $87.9 million, and management raised adjusted EBITDA guidance on visit growth and productivity improvements.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ā¢ Margin expansion ā¢ Liquidity pressure ā¢ Asset concentration LFST's quarterly profitability and cash flow improved materially, but weakening liquidity, rising net debt, intangible-heavy assets, and demanding valuation warrant caution.
Price Behavior
Key Price Behavior Insights: ā¢ Strong monthly uptrend ā¢ Resistance test ā¢ Pullback risk Support Level: $12.15ā$12.30 Resistance Level: $12.89ā$13.00 LFST remains in a last-month uptrend, but a break above $12.89ā$13.00 would confirm renewed strength while a fall below $12.15 may signal consolidation or reversal.
Sentiment & News
Key News Insights: ā¢ Analyst upgrades ā¢ Institutional inflow ā¢ Telehealth tailwinds LifeStance's bullish momentum reflects analyst upgrades, institutional buying, and favorable behavioral-health growth trends.
AI Summary
LFST has shifted from a profitability turnaround to an execution-and-valuation story: strong visit growth, pricing, EBITDA expansion, and free cash flow support further upside, but at ~25x EV/EBITDA investors should only add if mid-teens margins and cash conversion remain durable amid clinician-cost, reimbursement, and leverage risks.
Description
LifeStance Health Group, Inc. is a provider of outpatient mental health services delivering psychiatric assessment, psychological and neuropsychological testing, and various therapy modalities across the lifespan. The company treats a broad set of psychiatric conditions and offers care both in-person at centers across 32 states and through a virtual platform. Founded in 2017, LifeStance is headquartered in Scottsdale, Arizona.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Sep 10 | Sep 17 | LFST | LifeStance Health Group, Inc. | LFST gained 7.7% over 21 sessions and closed at a period high on September 10. Revenue grew 16%, free cash flow reached $87.9 million, and management raised adjusted EBITDA guidance on visit growth and productivity improvements. | Active | +0.0% |